Sean Smith
Plus aucun poste en cours
Profil
Sean Smith worked as a Senior Manager-Accounting at Aptevo Therapeutics, Inc. from 2017 to 2019.
He also worked as Vice President-Finance & Controller at Neoleukin Therapeutics, Inc. in 2022 and 2023.
Mr. Smith holds an MBA from the University of Washington and completed his undergraduate and graduate studies at the University of North Texas.
Anciens postes connus de Sean Smith
| Sociétés | Poste | Fin |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Comptroller/Controller/Auditor | 01/08/2019 |
| NEUROGENE INC. | Director of Finance/CFO | - |
Formation de Sean Smith
| University of Washington | Masters Business Admin |
| University of North Texas | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APTEVO THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
